Syzygium jambolanum and Cephalandra indica homeopathic preparations inhibit albumin glycation and protect erythrocytes: an in vitro study

Background: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia eventually resulting in long-term complications. Increased glycation of proteins is implicated in the pathogenesis of complications. For treatment of diabetes, Syzygium jambolanum and Cephalandra indica are frequently prescribed in homeopathy. However their role in glycation is not well elucidated. The present study aimed to evaluate the role of these homeopathic preparations in glycation induced structural modifications and further to examine their cellular protection ability.

Methods: In human erythrocytes, in vitro mother tincture and dilutions of S. jambolanum (Sj ф, 30c, 200c), C. indica (Ci ф, 30c, 200c) and standard antiglycator (AG) were compared and their antiglycation potential assessed by the estimating different markers of glycation (frcutosamines, carbonyls, bound sugar), structural modifications (free amino and thiol group). Phytochemical characterization (total phenolic, flavonoids and glycosides contents) was performed.

Results: The homeopathic preparations have different mode of action on albumin glycation modifications. Sj ф preparation demonstrated effective inhibition of all glycation, structural modifications except amino group protection. When dilutions were compared, Sj preparations showed reduction of glycation, structural modifications. All preparations showed significant erythrocyte protection. Sj ф preparation exhibited noteworthy antiglycation and cell protection ability as compared to AG.

Conclusion: These homeopathic preparations especially Sj ф prevented glycation induced albumin modifications and subsequent toxicity in human eryrthrocytre in vitro. Further investigation of their potential as antiglycators is justified.

Keywords

Glycation - Human erythrocytes - Homeopathic preparations - Syzygium jambolanum - Cephalandra indica

• References

• 1 Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
• 2 Cherian M., Abraham E.C. Glycation of human lens crystallins effect age and aspirin treatment. Ophthalmic Res 1993; 25: 349-354.
• 3 Niedowicz D.M., Daleke D.L. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289-330.
• 4 VanBoekel M.A.M., Hoenders H.J. Glycation of crystallins in lenses from aging and diabetic individuals. FEBS Lett 1992; 314: 1-4.
• 5 Beswick H.T., Harding J.J. Conformational changes induced in lens alpha- and gamma crystallins by modification with glucose 6-phosphate. Implications for cataract. Biochem J 1987; 246: 761-769.
• 6 Vlassara H. Advanced glycation end products and atherosclerosis. Ann Med 1996; 28: 419-426.
• 7 Modak M., Dixit P., Londhe J., Ghaskadbi S., Devasagayam T.P.A. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40: 163-173.
• 8 Rodrigues-Neto J.F., Figueiredo M.F., Faria A.A. Prevalence of the use of homeopathy by the population of Montes Claros, Minas Gerais, Brazil. Sao Paulo Med J 2009; 127: 329-334.
• 9 Ayyanar M., Subash-Babu P., Ignacimuthu S. Syzygiumcumini (L.) Skeels: a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences. Complement Ther Med 2013; 21: 232-243.
• 10 Pal A., Misra B.B., Das S.S., Gauri S.S., Patra M., Dey S. Antidiabetic effect of Cephalandra indica Q in diabetic rats. Ind J Res Homeo 2013; 7: 81-90.
• 11 Verma P.N., Vaid I. Encyclopaedia of homoeopathic pharmacopoeia of India and drug index. 4th edn vol. III 2007. New Delhi: B. Jain Publishers (P) Ltd.; 2380.
• 12 Verma P.N., Vaid I. Encyclopaedia of homoeopathic pharmacopoeia of India and drug index. 4th edn vol. I 2007. New Delhi: B. Jain Publishers (P) Ltd.; 722-723.
• 13 McPherson J.D., Shilton B.H., Walton D.J. Role of fructose in glycation and cross linking of proteins. Biochemistry 1988; 27: 1901-1907.
• 14 Baker J.R., Metcalf P.A., Johnson R.N., Newman D., Rietz P. Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem 1985; 31: 1550-1554.
• 15 Uchida K.M., Kanematsu K., Sakai T. et al. Protein-bound acrolein: potential markers for oxidative stress (Covalent modification of protein/antibody/atherosclerosis). Proc Nat Acad Sci U S A 1998; 95: 4882-4887.
• 16 Silvan J.M., Assar S.H., Srey C., Castillo M.D., Ames J.M. Control of Maillard reaction by ferulic acid. Food Chem 2011; 128: 208-213.
• 17 Ellman G.L. Tissue sulfhydrial groups. Arch Biochem Biophys 1959; 82: 70-77.
• 18 Aćimović J.M., Jovanović V.B., Veselinović M.R., Srećković V.D., Mandić L.M. Method for monitoring of the protein amino group changes during carbonylation. Clin Biochem 2011; 44: 994-999.
• 19 Singleton V.L., Rossi J.A. Colorimetry of total phenolics with phosphomolybdic–phosphotungstic acid reagents. Am J Enol Vitic 1996; 16: 144-153.
• 20 Sakanaka S., Tachibana Y., Okada Y. Preparation and antioxidant properties of extracts of Japanese persimmon leaf tea (kakinoha-cha). Food Chem 2005; 9: 569-575.
• 21 Dahiya P., Purkayastha S. Phytochemical screening and antimicrobial activity of some medicinal plants against multi-drug resistant bacteria from clinical isolates. Indian J Pharm Sci 2012; 74 (05) 443-450.
• 22 Konyalioglu S., Karamenderes C. The protective effects of Achillea L. species native in Turkey against H₂O₂-induced oxidative damage in human erythrocytes and leucocytes. J Ethnopharmacol 2005; 102: 221-227.
• 23 Guerin-Dubourg A., Catan A., Bourdon E., Rondeau P. Structural modifications of human albumin in diabetes. Diabetes Metab 2012; 38: 171-178.
• 24 Benzie I.F.F., Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Method Enzymol 1998; 299: 15-27.
• 25 Shinde J., Taldone T., Barletta M. et al. Alpha-Glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto–Kakizaki (GK) rats. Carbohydr Res 2008; 343: 1278-1281.
• 26 Singh N., Gupta M. Effects of Syzygium cumini (Linn.) seed powder on pancreatic islets of alloxan diabetic rats. Ind J Exp Biol 2007; 45: 861-867.
• 27 Krishnamoorthy P., Vaithinathan S., Bhuvaneswari A. Protective effect of Syzygium cumini (Linn.) Skeels seed extract on lipid peroxidation in alloxan induced diabetic rats. Nat Prodt Rad 2006; 5: 103-107.
• 28 Shibib B.A., Amin M.A., Mahbub Hasan A.K.M., Rahman R. A creeper, Coccinia indica, has anti-hyperglycaemic and anti-ureogenic effects in diabetic rats. J Pak Med Assoc 2012; 62: 145-1148.
• 29 Yadav G., Mishra A., Tiwari A. Medical properties of Ivy gourd (Cephalandra indica): a review. Int J Pharma Res Dev 2010; 2: 92-98.
• 30 Venkateswaran S., Pari L. Effect of Coccinia indica leaf extract on plasma antioxidants in streptozotocin- induced experimental diabetes in rats. Phytother Res 2003; 17: 605-608.
• 31 Venkateswaran S., Pari L. Effect of Coccinia indica leaves on antioxidant status in streptozotocin-induced diabetic rats. J Ethnopharmacol 2003; 84: 163-168.
• 32 Pari L., Venkateswaran S. Protective effect of Coccinia indica on changes in the fatty acid composition in streptozotocin induced diabetic rats. Pharmazie 2003; 58: 409-412.
• 33 Hossain M.Z., Shibib B.A., Rahman R. Hypoglycemic effects of Coccinia indica: inhibition of key gluconeogenic enzyme, glucose-6-phosphatase. Ind J Exp Biol 1992; 30: 418-420.
• 34 Shibib B.A., Khan L.A., Rahman R. Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6- phosphatase and fructose-1, 6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993; 292: 267-270.
• 35 Gunjan M., Jana G.K., Jha A.K., Mishra U. Pharmacognostic and antihyperglycemic study of Coccinia indica . Int J Phytomed 2010; 2: 36-40.
• 36 Deokate U.A., Khadabadi S.S. Pharmacology and phytochemistry of Coccinia indica . Pharmacophore 2012; 3: 179-185.
• 37 Ramakrishnan M., Bhuwanehwari R., Duraipandiyan V., Dhandapani R. Hypoglycemic activity of Coccinia indica weights and Arn. fruits in alloxan-induced diabetic rats. Ind J Nat Pro Reso 2011; 2: 350-353.
• 38 Sampath S., Narasimhan A., Chinta R. et al. Effect of homeopathic preparations of Syzygium jambolanum and Cephalandra indica on gastrocnemius muscle of high fat and high fructose-induced type-2 diabetic rats. Homeopathy 2013; 102: 160-171.
• 39 Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002; 81: 81-100.
• 40 Britto V.D., Devi P.P., Prasad B.L.V. et al. Medicinal plant extracts used for blood sugar and obesity therapy shows excellent inhibition of invertase activity: synthesis of nanoparticles using this extract and its cytotoxic and genotoxic effects. Int J life Sci Pharma Res 2012; 2: 61-74.
• 41 Steinmetz E.F. A botanical drug from the tropics used in the treatment of diabetes mellitus. Acta Phytother 1960; 7: 23.
• 42 Wu C.H., Huang S.M., Lin J.A., Yen G.C. Inhibition of advanced glycation end product formation by foodstuffs. Food Funct 2011; 2: 224-234.
• 43 Peng X., Cheng K.W., Ma J. et al. Cinnamon bark Proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycationendproducts. J Agr Food Chem 2008; 56: 1907-1911.
• 44 Baynes J.W., Thorpe S.R. Glycoxidation and lipoxidation in therogenesis. Free Radic Bio Med 2000; 28: 1708-1716.
• 45 Tupe R.S., Khaire A.A., Kemse N.G., Shaikh S.A. Inhibition of albumin glycation by Indian culinary plants extracts. Curr Top Nutraceut R 2013; 11: 75-82.
• 46 Adisakwattana S., Sompong W., Meeprom A., Ngamukote S., Yibchok-Anun S. Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation. Int J Mol Sci 2012; 13: 1778-1789.
• 47 Tupe R.S., Sankhe N.M., Shaikh S.A. et al. Aqueous extract of some indigenous medicinal plants inhibits glycation at multiple stages and protects erythrocytes from oxidative damage – An in vitro study. J Food Sci Tech Mys 2013. (in press), http://dx.doi.org/10.1007/s13197-013-1211-8.
• 48 Waczulíkova I., Sikurová L., Cársky J., Strbová L., Krahulec B. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylideneaminoguanidine. Gen Physiol Biophys 2000; 19: 381-392.
• 49 Khandagale A.N., Shanbhag D.A. Application of HPTLC in the standardization of a homoeopathic mother tincture of Syzygium Jambolanum . J Chem Pharm Res 2011; 3: 395-401.